These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 17675189

  • 21. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
    Mulder AM, Cravatt BF.
    Biochemistry; 2006 Sep 26; 45(38):11267-77. PubMed ID: 16981687
    [Abstract] [Full Text] [Related]

  • 22. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
    Bisogno T, De Petrocellis L, Di Marzo V.
    Curr Pharm Des; 2002 Sep 26; 8(7):533-47. PubMed ID: 11945157
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
    Maione S, Costa B, Piscitelli F, Morera E, De Chiaro M, Comelli F, Boccella S, Guida F, Verde R, Ortar G, Di Marzo V.
    Pharmacol Res; 2013 Oct 26; 76():98-105. PubMed ID: 23911581
    [Abstract] [Full Text] [Related]

  • 25. FAAH deficiency promotes energy storage and enhances the motivation for food.
    Touriño C, Oveisi F, Lockney J, Piomelli D, Maldonado R.
    Int J Obes (Lond); 2010 Mar 26; 34(3):557-68. PubMed ID: 20029375
    [Abstract] [Full Text] [Related]

  • 26. Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain.
    Rock EM, Limebeer CL, Parker LA.
    Psychopharmacology (Berl); 2018 Nov 26; 235(11):3259-3271. PubMed ID: 30225659
    [Abstract] [Full Text] [Related]

  • 27. Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and FAAH(+/+) mice.
    Wiley JL, Lefever TW, Pulley NS, Marusich JA, Cravatt BF, Lichtman AH.
    Behav Pharmacol; 2016 Aug 26; 27(5):479-84. PubMed ID: 27385208
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses.
    Zimmermann T, Bartsch JC, Beer A, Lomazzo E, Guggenhuber S, Lange MD, Bindila L, Pape HC, Lutz B.
    Neuropsychopharmacology; 2019 Jul 26; 44(8):1377-1388. PubMed ID: 30532004
    [Abstract] [Full Text] [Related]

  • 30. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
    Ortega-Gutiérrez S, Hawkins EG, Viso A, López-Rodríguez ML, Cravatt BF.
    Biochemistry; 2004 Jun 29; 43(25):8184-90. PubMed ID: 15209515
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
    Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM.
    BMC Biochem; 2009 May 21; 10():14. PubMed ID: 19460156
    [Abstract] [Full Text] [Related]

  • 33. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
    Hruba L, Seillier A, Zaki A, Cravatt BF, Lichtman AH, Giuffrida A, McMahon LR.
    J Pharmacol Exp Ther; 2015 May 21; 353(2):261-8. PubMed ID: 25711338
    [Abstract] [Full Text] [Related]

  • 34. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
    Smaga I, Bystrowska B, Gawliński D, Pomierny B, Stankowicz P, Filip M.
    Neurotox Res; 2014 Aug 21; 26(2):190-206. PubMed ID: 24652522
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA, Wise LE, Niyuhire F, Cravatt BF, Lichtman AH.
    Neuropsychopharmacology; 2007 May 21; 32(5):1032-41. PubMed ID: 17047668
    [Abstract] [Full Text] [Related]

  • 36. Assay of FAAH Activity.
    Bari M, Feole M, Maccarrone M.
    Methods Mol Biol; 2016 May 21; 1412():131-6. PubMed ID: 27245899
    [Abstract] [Full Text] [Related]

  • 37. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K, Ramer R, Dithmer S, Ivanov I, Merkord J, Hinz B.
    Oncotarget; 2016 Mar 22; 7(12):15047-64. PubMed ID: 26930716
    [Abstract] [Full Text] [Related]

  • 38. Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
    Pryce G, Cabranes A, Fernández-Ruiz J, Bisogno T, Di Marzo V, Long JZ, Cravatt BF, Giovannoni G, Baker D.
    Mult Scler; 2013 Dec 22; 19(14):1896-904. PubMed ID: 23625705
    [Abstract] [Full Text] [Related]

  • 39. Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in n-acylethanolamines in mouse brain.
    Lin L, Metherel AH, Jones PJ, Bazinet RP.
    J Neurochem; 2017 Sep 22; 142(5):662-671. PubMed ID: 28488728
    [Abstract] [Full Text] [Related]

  • 40. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
    De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, Di Marzo V.
    Fundam Clin Pharmacol; 2002 Aug 22; 16(4):297-302. PubMed ID: 12570018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.